246 related articles for article (PubMed ID: 36673048)
1. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.
Yang DH; Cheng J; Tian XF; Zhang Q; Yu LY; Qiu YJ; Lu XY; Lou WH; Dong Y; Wang WP
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673048
[TBL] [Abstract][Full Text] [Related]
2. Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced Ultrasound.
Lu XY; Guo X; Zhang Q; Qiu YJ; Zuo D; Chen S; Tian XF; Zhou YH; Dong Y; Wang WP
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36359506
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound (CEUS) and shear wave elastography (SWE) features for characterizing serous microcystic adenomas (SMAs): In comparison to pancreatic neuroendocrine tumors (pNETs).
Tian XF; Yu LY; Yang DH; Zuo D; Cao JY; Wang Y; Yang ZY; Lou WH; Wang WP; Gong W; Dong Y
Heliyon; 2024 Feb; 10(3):e25185. PubMed ID: 38327470
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.
Dong Y; Yang DH; Tian XF; Lou WH; Wang HZ; Chen S; Qiu YJ; Wang W; Dietrich CF
Br J Radiol; 2023 Sep; 96(1149):20220783. PubMed ID: 37393539
[TBL] [Abstract][Full Text] [Related]
5. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver.
Dong Y; Chen S; Möller K; Qiu YJ; Lu XY; Zhang Q; Dietrich CF; Wang WP
Ultrasound Med Biol; 2023 Aug; 49(8):1780-1788. PubMed ID: 37156676
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology.
Han X; Xu X; Ma H; Ji Y; Wang D; Kuang T; Wu W; Song B; Li G; Jin G; Lou W
Endocr Connect; 2018 Feb; 7(2):355-363. PubMed ID: 29472376
[TBL] [Abstract][Full Text] [Related]
7. VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.
Huang Y; Wang Y; Liu L; Zhu L; Qiu Y; Zuo D; Lu X; Dong Y; Jung EM; Wang W
Clin Hemorheol Microcirc; 2023; 83(4):409-420. PubMed ID: 36683500
[TBL] [Abstract][Full Text] [Related]
8. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
[TBL] [Abstract][Full Text] [Related]
10. Application of Dynamic Contrast-Enhanced Ultrasound in Evaluation the Activity of Crohn's Disease.
Wang Y; Wei L; Ge WS; Duan YR; Ding WJ; Lu XY; Huang YL; Chen S; Dong Y; Du P
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611585
[TBL] [Abstract][Full Text] [Related]
11. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
[TBL] [Abstract][Full Text] [Related]
12. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
[TBL] [Abstract][Full Text] [Related]
14. Application of dynamic contrast enhanced ultrasound analysis in predicting early response to systemic therapy of intrahepatic cholangiocarcinoma.
Lu XY; Jiang J; Chen S; Qiu YJ; Wang Y; Cheng J; Xu XL; Dong Y; Wang WP
Eur J Radiol; 2024 Jun; 175():111439. PubMed ID: 38547743
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine tumor: prediction of the tumor grade using magnetic resonance imaging findings and texture analysis with 3-T magnetic resonance.
Guo CG; Ren S; Chen X; Wang QD; Xiao WB; Zhang JF; Duan SF; Wang ZQ
Cancer Manag Res; 2019; 11():1933-1944. PubMed ID: 30881119
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades.
Salahshour F; Mehrabinejad MM; Zare Dehnavi A; Alibakhshi A; Dashti H; Ataee MA; Ayoobi Yazdi N
Abdom Radiol (NY); 2020 Oct; 45(10):3155-3162. PubMed ID: 31897681
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors.
Tomimaru Y; Eguchi H; Tatsumi M; Kim T; Hama N; Wada H; Kawamoto K; Kobayashi S; Morii E; Mori M; Doki Y; Nagano H
Surgery; 2015 Feb; 157(2):269-76. PubMed ID: 25311263
[TBL] [Abstract][Full Text] [Related]
18. The value of dynamic contrast enhanced ultrasound (DCE-US) in monitoring treatment effect of high-intensity focused ultrasound (HIFU) in locally advanced pancreatic cancer (LAPC).
Zuo D; Feng Y; Zhang Q; Qiu YJ; Tian XF; Shi SN; Dong Y; Liu TS; Wang WP
Clin Hemorheol Microcirc; 2021; 77(3):323-333. PubMed ID: 33252067
[TBL] [Abstract][Full Text] [Related]
19. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis1.
Yang D; Wang D; Qiu Y; Tian X; Zuo D; Dong Y; Lou W; Wang W
Clin Hemorheol Microcirc; 2022; 80(4):343-352. PubMed ID: 34602462
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
